Flowserve Corporation
FLSBusiness Model
source: coverage-next-full ticker: FLS step: "01" title: Business Overview — Segments, Products, End Markets created: 2026-05-29
Step 01 — Business Overview
Company Description
Flowserve Corporation is one of the world's leading manufacturers, distributors, and servicers of flow control products and services. The company designs, manufactures, and services pumps, valves, seals, and related flow control products for critical industrial processes where reliability and precision are paramount. Flowserve has operated for over 220 years (tracing roots to 1790) and is headquartered in Irving, Texas.
The business serves industries where flow control failure can result in catastrophic safety, environmental, or economic consequences — oil refineries, nuclear power plants, chemical processing facilities, water treatment plants, and pharmaceutical manufacturing. This mission-critical positioning is a cornerstone of its competitive moat.
Business Segments
1. Flowserve Pump Division (FPD) — ~55% of Revenue
FPD designs, manufactures, and services customized pumps and pump systems, complementary equipment, and related aftermarket parts and services.
Products:
- Centrifugal pumps (single-stage, multi-stage, large custom units)
- Positive displacement pumps (reciprocating, gear, screw)
- Nuclear pumps (highly specialized, safety-grade)
- Pump systems and engineered packages
End Markets Served:
- Oil & gas (exploration, production, refining, pipelines)
- Power generation (conventional, nuclear)
- Chemical/petrochemical processing
- Water and wastewater treatment
- General industrial
2. Flow Control Division (FCD) — ~45% of Revenue
FCD designs, manufactures, and services a portfolio of isolation and control valves, actuators, controls, and related equipment used in the management and regulation of fluid flow.
Products:
- Gate, globe, and check valves
- Ball, butterfly, and plug valves
- Control valves and regulating valves
- Actuators (pneumatic, electric, hydraulic)
- Solenoid valves
- Seals (mechanical seals, packing, gaskets)
- Valve automation and control systems
Notable brands under FCD: Valbart, Automax, Limitorque, Argus, Valtek, PMV, NAF, Gestra (industrial steam traps and valves)
Revenue by Type
| Revenue Type | Approx. % of Total |
|---|---|
| Original Equipment Manufacturing (OEM) | ~50% |
| Aftermarket / Services | ~50% |
The aftermarket component (replacement parts, repairs, upgrades, long-term service agreements) is the financial backbone of the business. Aftermarket revenues are:
- Higher margin than original equipment
- More recurring and less cyclical
- Driven by the installed base (100,000+ installed pumps and valves)
- Sticky due to proprietary parts, certifications, and safety requirements
End Market Exposure (Revenue %)
| End Market | ~% of Revenue |
|---|---|
| Oil & Gas | ~38–42% |
| Power Generation | ~18–22% |
| Chemical / Petrochemical | ~13–17% |
| Water / Wastewater | ~8–12% |
| General Industrial | ~12–16% |
Geographic Footprint
| Region | ~% of Revenue |
|---|---|
| Americas | ~40–45% |
| Europe, Middle East, Africa (EMEA) | ~35–40% |
| Asia Pacific | ~18–22% |
Flowserve operates in 55+ countries with ~55 manufacturing facilities and service/repair centers in over 170 locations. The Middle East (Saudi Aramco, ADNOC, downstream) is a meaningful contributor within EMEA.
Headcount and Scale
- ~17,000 employees globally
- ~$4.5B in annual revenue
- 55+ manufacturing facilities
- Service & repair centers: 170+ globally
Strategic Transformation: FLS 2.0
Launched in 2020 under CEO Scott Rowe, FLS 2.0 is a multi-year operational transformation program:
- Portfolio simplification — exited lower-margin, non-core product lines
- Manufacturing footprint optimization — consolidation of facilities, lean manufacturing
- Digital and commercial excellence — pricing discipline, CRM, digital service tools
- Margin expansion target — 17–18% adjusted EBIT margins (vs. ~13% at launch)
By FY2024, the company had achieved ~15–16% adjusted EBIT margins, demonstrating tangible progress. The final phase of FLS 2.0 targets ~200bps of additional improvement through continued operational leverage and volume growth.
Financial Snapshot
source: coverage-next-full ticker: FLS step: "04" title: Financial Snapshot — 3-Year P&L, Margins, EPS created: 2026-05-29
Step 04 — Financial Snapshot
Income Statement Summary (USD Millions)
| Metric | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Revenue | $4,126 | $4,375 | $4,542 |
| YoY Growth | — | +6.0% | +3.8% |
| Gross Profit | $1,247 | $1,380 | $1,465 |
| Gross Margin | 30.2% | 31.5% | 32.2% |
| Adj. EBIT | ~$545 | ~$630 | ~$700 |
| Adj. EBIT Margin | ~13.2% | ~14.4% | ~15.4% |
| GAAP Operating Income | ~$370 | ~$480 | ~$550 |
| GAAP EBIT Margin | ~9.0% | ~11.0% | ~12.1% |
| Net Interest Expense | ~($100) | ~($90) | ~($85) |
| Adj. Pre-tax Income | ~$445 | ~$540 | ~$615 |
| Tax Rate (adj.) | ~21–23% | ~21–22% | ~21–22% |
| Adj. Net Income | ~$345 | ~$420 | ~$480 |
| GAAP Net Income | ~$200 | ~$310 | ~$375 |
| Diluted Shares (M) | ~133 | ~132 | ~131 |
| Adj. Diluted EPS | ~$2.59 | ~$3.18 | ~$3.66 |
| GAAP Diluted EPS | ~$1.50 | ~$2.35 | ~$2.86 |
Note: Figures are approximations based on public filings and earnings releases. Adjusted metrics exclude restructuring/realignment charges, amortization of acquired intangibles, and certain other items.
Key Margin Analysis
Gross Margin Progression
- FY2022: 30.2% — Recovering from supply chain disruption and labor cost inflation
- FY2023: 31.5% — +130bps — Pricing actions, mix shift toward aftermarket, easing input costs
- FY2024: 32.2% — +70bps — Continued aftermarket mix improvement; higher-margin project completions
Gross margin target under FLS 2.0: 33–35% (full transformation maturity). Pathway requires continued aftermarket growth and volume leverage.
EBIT Margin Bridge FY2022 → FY2024
- +130bps — Gross margin expansion (pricing + mix)
- +80bps — SG&A leverage (fixed cost absorption on higher revenue)
- +30bps — R&D efficiency (rationalized investment)
- +130bps — One-time restructuring charges declining
- Net: ~+220bps adj. EBIT margin improvement over 2 years
Adj. EBIT Margin Target
- FLS 2.0 Phase 1 target (achieved ~2021): 12–13%
- FLS 2.0 Phase 2 target (achieved ~2023): 14–15%
- FLS 2.0 Phase 3 target (in progress): 17–18%
- Current (FY2024): ~15.4%
- Gap remaining: ~160–260bps to reach target range midpoint
EPS Growth Analysis
| Period | Adj. EPS | YoY Growth |
|---|---|---|
| FY2021 | ~$1.92 | — |
| FY2022 | ~$2.59 | +35% |
| FY2023 | ~$3.18 | +23% |
| FY2024 | ~$3.66 | +15% |
Strong EPS growth was driven by both operational margin expansion and modest share buyback activity. The growth rate is decelerating as the easier restructuring benefits have been captured and organic revenue growth normalizes.
FY2025E Consensus: ~$3.90–4.10 Adj. EPS (11–12% growth)
Restructuring / Non-Recurring Items
The gap between GAAP and Adjusted metrics is meaningful and declining:
| Item | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Restructuring / realignment | ~($85) | ~($65) | ~($45) |
| Amortization of intangibles | ~($75) | ~($75) | ~($75) |
| Other (gain/loss on divestitures, etc.) | Varies | Varies | Varies |
The declining restructuring charge is itself a sign that FLS 2.0 is maturing — most of the heavy lifting (facility closures, headcount reductions) is done.
EBITDA and Free Cash Flow
| Metric | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Adj. EBITDA | ~$680 | ~$780 | ~$860 |
| Adj. EBITDA Margin | ~16.5% | ~17.8% | ~18.9% |
| D&A | ~$135 | ~$150 | ~$160 |
| Capex | ~($130) | ~($120) | ~($130) |
| Free Cash Flow (FCF) | ~$280 | ~$380 | ~$450 |
| FCF Conversion (% of Adj. Net Income) | ~81% | ~90% | ~94% |
FCF conversion has been improving as working capital headwinds from revenue growth have partially normalized and restructuring cash costs have declined.
Dividend and Capital Returns
- Annual dividend: $0.80/share (~$105M total)
- Dividend yield: ~1.4–1.6% at typical trading prices
- Dividend payout ratio: ~22% of Adj. Net Income — conservative, well-covered
- Share buybacks: moderate (~$50–100M/year in FY2023–2024)
Recent Catalysts
source: coverage-next-full ticker: FLS step: "12" title: Catalysts — Near-Term Events, Bull Case, Bear Case created: 2026-05-29
Step 12 — Catalysts
Near-Term Catalysts (12–18 Months)
1. FLS 2.0 Phase 3 Margin Milestone
Timing: FY2025 full-year results (Feb 2026 earnings) Significance: If FLS achieves ~16.5–17% adj. EBIT margin in FY2025, it would confirm the final leg of the FLS 2.0 transformation is on track and narrow the remaining gap to the 17–18% target. This could drive a meaningful re-rating (market currently pricing ~15–16% as a "ceiling"). A FY2025 beat on margin guidance would be the single most important catalyst for multiple expansion.
2. Dividend Increase Announcement
Timing: H1 2025 (board meeting / annual report release)
Significance: Dividend has been flat at $0.80/share since ~2019. With leverage now at 0.6x Net Debt/EBITDA and FCF coverage of 4x, the case for a dividend increase is compelling. Even a modest 10–20% raise ($0.88–0.96/share) would signal confidence in sustainable earnings and attract income-oriented investors. This is a "known" catalyst that many FLS analysts have highlighted.
3. Backlog / Bookings Acceleration from Middle East NOC Awards
Timing: Q2/Q3 2025 earnings (project announcement timing uncertain) Significance: Saudi Aramco's Jafurah gas field development, ADNOC's multiple megaprojects, and Kuwait upstream expansion represent multi-year pump/valve procurement programs. A large FLS order announcement or accelerating bookings data would demonstrate demand durability beyond consensus expectations.
4. Clean Energy Project Wins (Hydrogen / Nuclear / LNG)
Timing: Ongoing, but could crystallize FY2025 Significance: FLS management has highlighted ~$500–750M in clean energy adjacent TAM by 2030. First material contract wins in nuclear SMR (e.g., NuScale, X-energy project specification), a large green hydrogen facility, or a carbon capture project would validate the diversification story. Currently priced as a "show me" — any confirmation would be positive.
5. Share Repurchase Acceleration
Timing: Ongoing Significance: With $1.48B liquidity and net leverage at 0.6x, FLS has capacity to meaningfully accelerate buybacks from $100M/year toward $200–250M/year. An increased buyback authorization or acceleration announcement would be modestly positive. At current prices, each 1% share count reduction is ~$0.04/share Adj. EPS accretive.
6. Tariff Resolution / Trade Policy Clarity
Timing: Ongoing (geopolitically uncertain) Significance: If the 2025 tariff/trade environment stabilizes or is partially resolved (steel/aluminum tariffs), FLS's ~$15–25M annual cost headwind could be reduced. This is an upside optionality rather than a core thesis.
Bull Case
Bull Case
- FLS 2.0 delivers the final 200bps of margin expansion to reach 17–18% adj. EBIT, driving substantial EPS upside ($4.50–5.00 Adj. EPS by FY2026) and a re-rating toward 22–24x earnings, implying $99–120 target price
- Aftermarket revenue accelerates through LTSAs and RedRaven digital contracts, increasing revenue visibility and expanding multiples toward IDEX-like levels as the market recognizes recurring revenue durability
- Middle East NOC capex supercycle (Saudi Vision 2030, ADNOC 5-year plan) drives above-consensus bookings growth through 2027, with clean energy wins in nuclear and hydrogen adding a new long-duration growth vector
Bear Case
- Oil price collapses to $55–60/bbl on OPEC+ overproduction and demand destruction, triggering a 10–15% cut in global O&G capex that hits FLS OEM bookings hard and stalls the margin expansion trajectory at ~15%, disappointing investors who have priced in the FLS 2.0 completion
- FLS 2.0 final-mile margin execution disappoints — manufacturing consolidation savings do not fully materialize, pricing discipline erodes in a softer demand environment, and adj. EBIT margin plateaus at 15–16% rather than reaching the 17–18% target, removing the re-rating catalyst
- Multiple compression from rising rates or risk-off rotation — at ~20x forward earnings, FLS is priced for continued execution; any combination of earnings miss, guidance cut, or broader industrial de-rating compresses the stock toward 16–17x, implying meaningful downside from current levels
Full Research Available
This primer covers steps 1–3 of 21. The full deep dive includes moat analysis, DCF valuation, bull/bear scenarios, management quality, earnings transcript analysis, competitive positioning, returns on capital, institutional/insider activity, and an investment memo.